Skip to main content
Equibles

ORBIMED ADVISORS LLC

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1055951 New York, NY
Back to RYTM Full portfolio

Position in RYTM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$35,851,587
+$8,534,310 QoQ
Shares Held
322,900
+2.8% QoQ
Ownership
0.469%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 40% Shared 0% None 60%

Common Shares in RYTM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. RYTM ranks #28 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EWTX
Edgewise Therapeutics, Inc.
 15,518,492 $630,516,329
2 ELVN
Enliven Therapeutics, Inc.
 6,776,632 $343,914,074
3 MBX
MBX Biosciences, Inc.
 3,428,736 $189,266,227
4 GPCR
Structure Therapeutics Inc.
 2,209,400 $118,578,498
5 SION
Sionna Therapeutics, Inc.
 2,555,877 $112,433,029
6 CRVS
Corvus Pharmaceuticals, Inc.
 7,165,006 $107,045,189
7 AVBP
ArriVent BioPharma, Inc.
 3,027,328 $105,169,374
8 ARGX
Argenx SE
 92,880 $86,171,277

All Filings in RYTM

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $35,851,587 322,900
2026-03-31 $27,317,277 314,100
2025-12-31 $25,668,192 239,800
2025-09-30 $21,728,200 215,152
2025-06-30 $15,703,473 248,512
2025-03-31 $20,128,600 380,000
2024-12-31 $22,392,000 400,000
2024-09-30 $22,836,801 435,900
2024-06-30 $28,940,812 704,842
2024-03-31 $30,540,803 704,842
2023-12-31 $24,669,432 536,642
2023-09-30 $13,379,992 583,642